StockWatch
·
Biotechnology: Pharmaceutical Preparations
Management ChangeMay 13, 2026, 08:07 AM

Ironwood CFO Gregory Martini Resigns; Ronald Silver Named Interim CFO

AI Summary

Gregory Martini resigned from his position as Senior Vice President, Chief Financial Officer of Ironwood Pharmaceuticals, effective May 15, 2026. His resignation is not due to any disagreement with the company's financial reporting. Ronald Silver, currently the Senior Vice President, Corporate Controller and Chief Accounting Officer, will assume the role of interim chief financial officer and principal financial officer, effective the same date. Silver has been with the company since June 2018, holding various accounting and financial reporting roles.

Key Highlights

  • Gregory Martini resigned as Senior Vice President, Chief Financial Officer of Ironwood Pharmaceuticals.
  • Martini's resignation is effective May 15, 2026, and is not due to any disagreement.
  • Ronald Silver appointed interim Chief Financial Officer and principal financial officer.
  • Silver's interim appointment is effective May 15, 2026.
  • Silver currently serves as Senior Vice President, Corporate Controller and Chief Accounting Officer.
  • Silver joined Ironwood in June 2018 and is a Certified Public Accountant.